Michaela Bossart

ORCID: 0000-0003-3218-912X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian cancer diagnosis and treatment
  • Endometrial and Cervical Cancer Treatments
  • Uterine Myomas and Treatments
  • Testicular diseases and treatments
  • Cervical Cancer and HPV Research
  • Advances in Oncology and Radiotherapy
  • Sarcoma Diagnosis and Treatment
  • Estrogen and related hormone effects
  • Endometriosis Research and Treatment
  • Intraperitoneal and Appendiceal Malignancies
  • Lung Cancer Research Studies
  • Diversity and Career in Medicine
  • Cancer Treatment and Pharmacology
  • Ovarian function and disorders
  • Surgical Simulation and Training
  • Cancer survivorship and care
  • Cardiac, Anesthesia and Surgical Outcomes
  • Innovations in Medical Education
  • Breast Cancer Treatment Studies
  • Radiology practices and education
  • Peptidase Inhibition and Analysis
  • Machine Learning in Bioinformatics
  • Appendicitis Diagnosis and Management
  • HER2/EGFR in Cancer Research
  • Molecular Biology Techniques and Applications

University of Freiburg
2010-2023

University Medical Center Freiburg
2011-2023

Klinik für Frauenheilkunde
2023

St. Josefskrankenhaus Freiburg
2021-2022

Universitäts Frauenklinik
2011-2020

Universitätsklinik für Frauenheilkunde und Geburtshilfe
2020

Royal Adelaide Hospital
2017

Olgahospital
2016

A good educational climate/environment in the workplace is essential for developing high-quality medical (sub)specialists. These data are lacking gynecological oncology training.This study aims to evaluate climate training throughout Europe and factors affecting it.A Web-based anonymous survey sent ENYGO (European Network of Young Gynecological Oncologists) members/trainees assess training. This included sociodemographic information, details regarding posts, a 50-item validated Dutch...

10.1097/igc.0000000000000323 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2015-01-01

Abstract Background Trial on five plasma biomarkers (CA125, HE4, OPN, leptin, prolactin) and their possible role in differentiating benign from malignant ovarian tumors. Methods In this unicentric prospective trial preoperative blood samples of 43 women with masses determined for surgery were analyzed. 25 patients had pathologically confirmed benign, 18 Blood was analyzed CA125, prolactin MIF by multiplex immunoassay analysis. Each single protein a logistical regression model including all...

10.1186/s12885-021-08682-y article EN cc-by BMC Cancer 2021-09-16

The objectives of the study were to highlight some differences in training systems and opportunities for gynecologic oncology across Europe draw attention steps that can be taken improve prospects experiences European trainees oncology.The Network Young Gynaecological Oncologists national representatives from 34 countries asked review summarize system their origin fulfill a mini-questionnaire evaluating different aspects training. We report analysis outcomes subsequent discussion at Asian...

10.1097/igc.0b013e3182202d17 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2011-06-30

The objective of this study was to highlight the relative preference European gynecologic oncology trainees for workshops that could support and supplement their training needs.A Web-based survey sent 900 on Network Young Gynaecological Oncologists database in November 2011. Respondents were asked rate a 13-item questionnaire (using 1- 5-point Likert scale) workshop topics they felt would most benefit requirements. Free text space additional also provided. Descriptive analysis used describe...

10.1097/igc.0b013e31829703b0 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2013-06-21

Abstract Purpose Uterine sarcoma (US) as a histologically heterogeneous group of tumors is rare and associated with poor prognosis. Prognostic factors based on systematic data collection need to be identified optimize patients’ treatment. Methods This unicenter, retrospective cohort study includes 57 patients treated at the University Hospital Freiburg, Germany between 1999 2017. Progression-free survival (PFS) overall (OS) were calculated visualized in Kaplan–Meier curves. using log-rank...

10.1007/s00404-022-06515-2 article EN cc-by Archives of Gynecology and Obstetrics 2022-07-03

There is limited information about the impact of radical surgery including pelvic and para-aortic lymphadenectomy subsequent platinum-based chemotherapy on sexuality in patients with advanced ovarian cancer.To evaluate cancer as a sub-protocol prospectively randomized LION trial.The Sexual Activity Questionnaire was applied to assess sexual function according its sub-scales activity, pleasure, discomfort. The 'orgasm' sub-scale from Female Function Index also added. questionnaire...

10.1136/ijgc-2020-001551 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2020-09-16

Gender-related differences in career development are well known issues various professions. An international survey on gender-related was performed among young gynecologic oncology surgeons Europe to identify potential gender inequalities development.

10.3389/fonc.2022.1005130 article EN cc-by Frontiers in Oncology 2022-12-07

Abstract Introduction The intention of this study was to evaluate the level anxiety and depression malignant ovarian germ cell (MOGCT) sex cord stromal tumors (SCST) survivors identify possible alterable cofactors. Methods CORSETT an observational, multicenter, mixed retrospective/prospective cohort AGO Studygroup. Women who had been diagnosed with MOGCTs SCSTs between 2001 2011 were asked complete Hospital Anxiety Depression Scale (HADS) distress. Predictors distress (type surgery,...

10.1007/s00404-022-06781-0 article EN cc-by Archives of Gynecology and Obstetrics 2022-09-21

Abstract Purpose Malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST) are neoplasms that affect disproportionally young women. Little is known about the impact of surgical adjuvant management these patient’s sexual life. This study investigated effect fertility-sparing surgery on activity global quality life (gQoL) in women with MOGCT SCST. Methods CORSETT was an observational, multicenter, mixed retrospective/prospective cohort AGO group. Women any age who had been...

10.1007/s00404-021-06019-5 article EN cc-by Archives of Gynecology and Obstetrics 2021-07-21

5575 Background: There is limited information regarding the impact of radical surgery including pelvic and para-aortic lymphadenectomy (LNE) subsequent chemotherapy on sexuality in patients (pts.) with advanced ovarian cancer (AOC). We addressed this question within prospectively randomized LION trial, evaluating role LNE AOC. Methods: The Sexual Activity Questionnaire (SAQ) was used to assess sexual function terms its subscales activity, pleasure, discomfort. Additionally we added "orgasm"...

10.1200/jco.2018.36.15_suppl.5575 article EN Journal of Clinical Oncology 2018-05-20

Introduction Advanced minimal access surgical training is an important component of in gynecological oncology (GO). Europe-wide data on this topic are lacking. We present availability and trainee experience advanced laparoscopic (ALS) robotic (RS) GO across Europe. Method A prospective web-based anonymized survey European trainees was sent to the Network Young Gynaecological Oncologists members/trainees. It included sociodemographic information specific questions pertaining or satisfaction...

10.1097/igc.0000000000000879 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2017-01-21

The aim of this study was to calculate the validity parameters Digene Hybrid Capture 2 (HC2) high-risk human papillomavirus DNA test with and without cytology in follow-up examinations after laser treatment transformation zone or large loop excision (LLETZ) for cervical intraepithelial neoplasia (CIN).We performed a standardized examination 113 postlaser 153 post-LLETZ patients our colposcopy clinic. Routine cytology, HC2 tests, colposcopically-guided biopsies were sensitivity, specificity,...

10.1097/lgt.0000000000000348 article EN Journal of Lower Genital Tract Disease 2017-09-27

Abstract Purpose: Uterine sarcoma (US) as a histologically heterogeneous group of tumors is rare and associated with poor prognosis. Prognostic factors based on systematic data collection need to be identified optimize patients’ treatment. Methods: This unicenter, retrospective cohort study includes 57 patients treated at the University Hospital Freiburg, Germany between 1999 2017. Progression-free survival (PFS) overall (OS) were calculated visualized in Kaplan-Meier curves. using log-rank...

10.21203/rs.3.rs-1255252/v1 preprint EN cc-by Research Square (Research Square) 2022-01-19

Objective Unicentric analysis of a study on 5 serum biomarkers (CA 125, HE 4, OPN, Leptin, Prolactin) and their possible role in discriminating benign from malignant ovarian tumours.

10.1055/s-0040-1718132 article EN Geburtshilfe und Frauenheilkunde 2020-10-01

<h3>Introduction/Background</h3> Malignant sex cord stroma cell tumours (SCST) account for less than eight percent of ovarian malignancies. The Arbeitsgemeinschaft fuer Gynaekologische Onkologie (AGO) has established a clinicopathological (Current Ovarian geRm and SEx stromal Tumour Treatment strategies, CORSETT) database better documentation understanding this rare disease. Here, we present the first descriptive analysis patients with independently confirmed SCST from CORSETT database....

10.1136/ijgc-2020-esgo.111 article EN Ovarian cancer 2020-12-01

<h3>Introduction/Background*</h3> Trial on five plasma biomarkers (CA125 – cancer antigen 125, HE4 human epididymis protein 4, OPN - osteopontin, leptin, prolactin) and their possible role in differentiating benign from malignant ovarian tumors. <h3>Methodology</h3> In this unicentric prospective trial preoperative blood samples of 43 women with masses determined for surgery were analyzed. 25 patients had pathologically confirmed benign, 18 Blood was analyzed CA125, HE4, OPN, prolactin MIF...

10.1136/ijgc-2021-esgo.371 article EN Ovarian cancer 2021-10-01
Coming Soon ...